---
title: "Rockwell Medical, Inc. (RMTI.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/RMTI.US.md"
symbol: "RMTI.US"
name: "Rockwell Medical, Inc."
industry: "Health Care Supplies"
---

# Rockwell Medical, Inc. (RMTI.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Location | US Market |
| Website | [www.rockwellmed.com](https://www.rockwellmed.com) |

## Company Profile

Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-16T04:30:12.000Z

**Overall: C (0.58)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 27 / 43 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -23.60% |  |
| Net Profit YoY | -315.92% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.08 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 39.80M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 75.58M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -17.93% | E |
| Profit Margin | -7.30% | D |
| Gross Margin | 14.27% | D |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -23.60% | E |
| Net Profit YoY | -315.92% | E |
| Total Assets YoY | 0.70% | C |
| Net Assets YoY | 27.06% | A |

#### Cash Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -1274.27% | E |
| OCF YoY | -23.60% | E |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.32 | A |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 35.60% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Rockwell Medical, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-17.93%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-7.30%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "14.27%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-23.60%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-315.92%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "0.70%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "27.06%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "E",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-1274.27%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-23.60%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.32",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "35.60%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Essilor (US.ESLOY) | B | B | C | B | B | B |
| 02 | HOYA Corporation (US.HOCPY) | A | B | B | A | C | B |
| 03 | Align (US.ALGN) | B | C | B | B | C | B |
| 04 | Merit Medical (US.MMSI) | B | B | B | C | B | B |
| 05 | UFP Tech (US.UFPT) | B | B | A | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -6.71 | 33/44 | - | - | - |
| PB | 1.08 | 10/44 | 1.38 | 1.16 | 1.02 |
| PS (TTM) | 0.53 | 5/44 | 0.53 | 0.43 | 0.35 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-26T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 50% |
| Overweight | 1 | 50% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.01 |
| Highest Target | 5.00 |
| Lowest Target | 2.50 |

## References

- [Company Overview](https://longbridge.com/en/quote/RMTI.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/RMTI.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/RMTI.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.